Private
The U.S. Army has awarded a $26 million contract modification to FLIR Systems, Inc. to support the Nuclear, Biological and Chemical Reconnaissance Vehicle Sensor Suite Upgrade (NBCRV SSU).
“Our ability to build and integrate manned and unmanned sensing solutions across a wide threat space is... Read More »
Another COVID-19 vaccine candidate shows promise for antibodies produced, at least in preclinical results released by Sanofi Pasteur and Translate Bio last week for their mRNA-based offering, MRT5500.
The candidate produced neutralizing antibodies against SARS-CoV-2 -- the virus that causes... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Beckman Coulter are joining forces to fund a multi-center clinical trial of Beckman Coulter’s Monocyte Distribution Width (MDW) hematology biomarker, a test meant to rapidly detect MIS-C.
MIS-C, or Multisystem Inflammatory... Read More »
A new Center for American Progress report details methods the United States can use to address expanding Huawei market and national security challenges and its 5G network building role.
The analysis maintains America has ignored the policies Beijing uses to make the tech company Huawei the... Read More »
The U.S. Food and Drug Administration (FDA) authorized a major medical breakthrough this week, approving Regeneron Pharmaceuticals to produce Inmazeb, the first treatment for Ebola virus infections to reach that point.
Inmazeb is a mix of three monoclonal antibodies, which work by targeting the... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) launched a study to determine whether certain approved therapies or investigational drugs show promise against COVID-19.
The ACTIV-5 Big Effect Trial is being conducted in partnership with the National Institutes of Health’s... Read More »
Sen. Susan Collins (D-ME) recently addressed the new $25 million LymeX initiative, which was announced this week in partnership between the U.S. Department of Health and Human Services and the Stephen and Alexandra Cohen Foundation.
LymeX is the largest public-private partnership to combat Lyme... Read More »
A $481 million award from the Biomedical Advanced Research and Development Authority (BARDA) and Department of Defense (DoD) this week will help Cue Health, Inc. expand the production capacity of a cartridge-based point-of-care molecular test for COVID-19.
With the fund injection, Cue aims to... Read More »
Massachusetts-based Cytiva will partner with the U.S. Departments of Health and Human Services (HHS) and Defense (DoD) to expand its manufacturing capacity for COVID-19 vaccine components and aid the federal Operation Warp Speed.
Operation Warp Speed is focused on bending U.S.-based... Read More »
The U.S. Departments of Health and Human Services (HHS) and Defense (DoD) announced greater collaboration with AstraZeneca last week, specifically aimed at the late-stage development and manufacturing of its COVID-19 treatment, AZD7442.
AZD7442 is a drug cocktail made up of two monoclonal... Read More »
At the virtual LymeMIND conference last week, the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation announced they would partner on a $25 million endeavor known as the LymeX Innovation Accelerator.
LymeX will be the largest Lyme disease-focused... Read More »
Election interference has sounded many alarms this year, all the way to the White House and the halls of Congress. Now, the Rand Corporation is warning that a coordinated effort on Twitter to influence and provoke chaos during the upcoming presidential election is underway.
“Social media has... Read More »
Under a new partnership, the Biomedical Advanced Research and Development Authority (BARDA) will collaborate with Current Health to develop an algorithm based on a Food and Drug Administration (FDA) approved wearable monitor to predict the need for COVID-19 hospitalization.
By forecasting the... Read More »
Emergent BioSolutions Inc. is one of four companies collaborating to provide hyperimmune globulin products for a new federal clinical trial that will test the safety, tolerability and efficacy of a combination treatment regimen for COVID-19.
The regimen consists of the antiviral remdesivir plus... Read More »
U.S. Space Force personnel said the agency’s Boeing-developed Wideband Global SATCOM (WGS)-11+ communications satellite successfully completed its first major engineering design review.
“Completing this engineering design review is a key milestone and brings us one step closer to delivering... Read More »
A new test being developed by molecular diagnostics company Cepheid gained support from federal agencies this week, on the promise that it could become a one-stop-shop for diagnosing COVID-19, influenza, and RSV.
Support is coming from the Biomedical Advanced Research and Development Authority... Read More »
Biological materials management and standards organization ATCC has secured a potential 10-year, Indefinite Delivery/Indefinite Quantity (IDIQ) contract award from the Biomedical Advanced Research and Development Authority (BARDA).
The agreement, which possesses a ceiling value of $250 million,... Read More »
Over the course of three years, the Biomedical Advanced Research and Development Authority (BARDA) will pay approximately $22 million to Vaxxas to fund phase 1 clinical trials in the U.S. and Australia for a high-density microarray patch capable of administering vaccines needle-free.
This comes... Read More »
A joint effort between the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) brought $98.35 million to COVID-19 testing efforts this week, as part of six contracts awarded under the Rapid Acceleration of Diagnostics (RADx) initiative.
The... Read More »
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) -- a global non-profit dedicated to antibacterial research – is awarding up to $2.5 million to GangaGen Biotechnologies to develop novel antibacterial proteins.
GangaGen, based in Bangalore, India, will develop... Read More »
The professional services firm KBR, Inc. has completed the acquisition of independent provider of space, directed energy, and advanced technology solutions Centauri, LLC from Arlington Capital Partners.
The acquisition expands KBR's military space and intelligence business, as well as the... Read More »
National Institute of Standards and Technology (NIST) researchers maintain they have developed a means of increasing primary SARS-CoV-2 virus testing sensitivity to help identify those who are asymptomatic.
Findings published in Analytical and Bioanalytical Chemistry outlined a mathematical... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has partnered with Mapp Biopharmaceutical, Inc. to develop a new monoclonal antibody therapeutic for all seven major types of Botulinum Neurotoxin.
Botulinum is an incredibly lethal substance responsible for botulism, though it... Read More »
Department of Homeland Security (DHS) said personnel within the agency’s Targeted Violence and Terrorism Prevention program (TVTP) recently hosted its fifth Digital Forum on Terrorism Prevention.
The initiative primarily involved Atlanta-based civil society leaders, providing an opportunity... Read More »
Following three successful clinical trials, Veklury (remdesivir) is now available for hospital purchase directly from its distributor, Gilead Sciences, ending the government’s distribution role.
The move follows five months during which the U.S. government managed allocation and distribution... Read More »
With an initial five laboratories, the Coalition of Epidemic Preparedness Innovations (CEPI) has launched a network of labs worldwide, collectively focused on helping COVID-19 vaccine developers uniformly evaluate and identify successful candidates.
By centralizing, the hope is to assess and... Read More »
As part of a community-focused move, particularly among schools, the United States Department of Health and Human Services (HHS) and The Rockefeller Foundation have agreed to identify and share effective approaches for using rapid point-of-care antigen tests to screen for COVID-19.
The pilot... Read More »
Sandia National Laboratories personnel are espousing the benefits of its Sandia Programs Engineering and Assembly Research (SPEAR) facility, which officials said would expand weapons modernization testing capacity.
Lisa E. Gordon-Hagerty, administrator of the National Nuclear Security... Read More »
A pair of investigational drugs targeting antibiotic-resistant infections will receive nearly $20 million in initial funding from the Biomedical Advanced Research and Development Authority (BARDA) to support phase two and three clinical trials and other efforts to reach U.S. Food and Drug... Read More »
The United Nations reported a major milestone this week for the global Access to COVID-19 Tools (ACT) Accelerator initiative, collecting nearly $1 billion in new financing to guarantee tests, treatment and vaccines for COVID-19.
The ACT Accelerator is a joint effort by the World Health... Read More »
The Denver Health and Hospital Authority signed a $3 million cooperative agreement with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to demonstrate the effectiveness of a Regional Disaster Health Response System... Read More »
A phase one trial of a COVID-19 vaccine jointly developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna, Inc. brought positive results, triggering strong immune responses among older volunteers while proving well-tolerated.
According to a report published this... Read More »
BARDA is partnering with Inversa to develop a treatment for eye problems associated with DNA damage, particularly those caused by chemical agents like sulfur mustard gas.
Ingrained in the public mind since its widespread use in WWI, sulfur mustard is a means of chemical warfare that causes the... Read More »
A new report from the Nuclear Threat Initiative (NTI) says some gaps need to be addressed in the international system to prevent and respond to biological events.
NTI is calling on national and global leaders to take action now to prevent future biological events that could match or exceed the... Read More »
Cecil County, Maryland officials said first responders there are recipients of a new, purpose-built FirstNet cell site - providing a boost in wireless communications.
"This is great news for Earleville, Cecil County, and the surrounding areas,” Maryland State Sen. Steve Hershey (R-Dist. 36)... Read More »
